Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion

Priscilla Romina De Gregorio,Carola Parolin,Angela Abruzzo,Barbara Luppi,Michele Protti,Laura Mercolini,Jessica Alejandra Silva,Barbara Giordani,Antonella Marangoni,María Elena Fátima Nader-Macías,Beatrice Vitali
DOI: https://doi.org/10.1186/s12934-020-01390-5
IF: 6.352
2020-06-18
Microbial Cell Factories
Abstract:Lactobacillus spp. dominating the vaginal microbiota of healthy women contribute to the prevention of urogenital and sexually transmitted infections. Their protective role in the vagina can be mediated by Lactobacillus cells themselves, metabolites or bacterial components, able to interfere with pathogen adhesion and infectivity. Vulvovaginal candidiasis (VVC) is a common genital infection, caused by the overgrowth of opportunistic Candida spp. including C. albicans, C. glabrata, C. krusei and C. tropicalis. Azole antifungal drugs are not always efficient in resolving VVC and preventing recurrent infections, thus alternative anti-Candida agents based on vaginal probiotics have gained more importance. The present work aims to chemically characterize the biosurfactant (BS) isolated from a vaginal Lactobacillus crispatus strain, L. crispatus BC1, and to investigate its safety and antiadhesive/antimicrobial activity against Candida spp., employing in vitro and in vivo assays.
biotechnology & applied microbiology
What problem does this paper attempt to address?